__NUXT_JSONP__("/drugs/Mivebresib", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1445993-26-9",chebiId:b,chemicalFormula:b,definition:"An inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, with potential antineoplastic activity. Upon administration, mivebresib binds to the acetyl-lysine binding site of  BRD-containing protein(s), thereby preventing the interaction between those proteins and acetylated histones. This disrupts chromatin remodeling, prevents the expression of certain growth-promoting genes, and leads to an inhibition of cell growth in susceptible tumors.",fdaUniiCode:"VR86R11J7J",identifier:"C121829",preferredName:a,semanticType:"Organic Chemical",subclassOf:["C128462"],synonyms:["ABBV-075","Ethanesulfonamide, N-(4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo(2,3-C)pyridin-4-yl)phenyl)-","MIVEBRESIB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FMivebresib",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Mivebresib","","2021-10-30T13:20:19.973Z")));